Share/Refer CSATC

Doctor Administers medical Marijuana

Keeping You Informed

CSATC - New Jersey Medical Marijuana Dispensary

News

Gorilla Glue Garlic Herbed Gravy

Gorilla Glue is a great strain for conditions including Lyme disease, chronic pain, glaucoma and can help stimulate one’s appetite. The earthy flavor pairs well with the garlic/basil/parsley flavors.

 

Ingredients:
½ Cup Gorilla Glue Garlic Herbed Butter
½ Cup Flour
4 Cups Chicken Stock
1/3 Cup Heavy Cream
 
Directions:
Cut Garlic Butter into chunks and melt on stove.
Add ½ cup flour and whisk until blended.
Continue whisking until it smells like a pie is cooking!
This may take 6-12 minutes.
Add chicken stock, one cup at a time until fully blended.
Then add the heavy cream, whisking until it coats the back of a spoon.

Posted on in category: Patient Recipes | Comments Off on Gorilla Glue Garlic Herbed Gravy

Gorilla Glue Garlic Herbed Butter

Gorilla Glue is a great strain for conditions including Lyme disease, chronic pain, glaucoma and can help stimulate one’s appetite. The earthy flavor pairs well with the garlic/basil/parsley flavors.
Ingredients:
1/8 oz. Gorilla Glue
1 Cup Butter, Softened
1 Clove Garlic, pressed
2/3 Cup Chopped Basil
¼ Cup Fresh Parsley
2/4 teaspoon of salt

 

Directions:
Decarboxylate cannabis in covered, oven safe dish at 240 degrees for 45 minutes.

Place in crockpot with ½ cup of butter on low for 2 hours.
Do not strain.
Put in refrigerator until more solidified, but not completely hardened.
Stir in garlic, basil, parsley and salt until well blended.

Posted on in category: Patient Recipes | Comments Off on Gorilla Glue Garlic Herbed Butter

Strain Focus: AC/DC

At Compassionate Sciences, we provide a sativa dominant AC/DC strain, to be available by June 22, which exhibits relaxed and uplifted effects that patients say works great for seizure disorders, Multiple Sclerosis, spasms, gastrointestinal distress, anxiety, chronic pain, stress inflammation and depression.

This high CBD strain has countless sought after medicinal benefits, and does not produce psychotropic effects. When mixed with high THC strains it can take away the psychotropic effects of THC, while still allowing patients to receive the medicinal benefits of both strains.

AC/DC is a hybrid cross of MK ultra and G13 Haze. MK Ultra is named after a CIA Project that implemented mental manipulation methods, and is known for its strong and fast acting “hypnotic” effects. G13 Haze is a hybrid producing uplifting sensations while retaining a heavy indica undertone. Renowned for its medical use, G13 Haze was bred for potency. The cross of MK Ultra and G13 Haze resulted in AC/DC, a phenotype of the cannabis strain Cannatonic.

With its distinct lineage and wide range of medicinal benefits, AC/DC is a patient favorite.

 

Click to read more about strains at CSATC.

Posted on in category: Strain Highlight | Comments Off on Strain Focus: AC/DC

Patients Not Allowed to Smoke in Seaside Boardwalk’s Smoking Section

Patients were told that smoking medical cannabis on the Seaside Boardwalk, even if it is in the designated smoking section, is not allowed. Although patients have the right to smoke where the law allows them, there are restrictions that limit medicating in certain public places.

Michelle Burns, who suffers from multiple sclerosis, was quickly interrupted while trying to medicate in the designated smoking section on the boardwalk.

As shown in this video, she was confronted by a group of officers, one of the officers stated that no one has ever even explained the “medical marijuana” laws to them. Even though it is argued in the video that CUMMA allows medical marijuana patients to smoke where the Clean Air Act permits them, there are exceptions to the overarching rule. CSATC encourages all patients to review CUMMA and to respect the guidelines provided by the Department of Health stated below.

The Department of Health provides guidelines for patients which say:

“Patients are encouraged to use medicinal marijuana only in their residence. Patients may not smoke medicinal marijuana in a school bus, on public transportation, or in a private vehicle while in motion. Additionally, patients may not smoke medicinal marijuana on any school grounds or at any correctional facility, public park, beach, recreation center or other places where smoking is prohibited.” 

The officers clarified that the boardwalk is considered a recreation area, and this understanding was reinforced at a subsequent council meeting. The borough attorney said that they may consider altering this rule. Overall, it did not seem to be a hostile encounter with the police officers. The patients in the video were cooperative and understanding, and the officers gave suggestions on where they could medicate without being bothered by law enforcement.

Posted on in category: New Jersey News | Tagged , , | Comments Off on Patients Not Allowed to Smoke in Seaside Boardwalk’s Smoking Section

CSATC’s Improvements, New Strains and More

Since CSATC entered the cannabis industry in New Jersey, our goal has always been to continue to improve the Medical Marijuana Program. We recognize the realities of being a patient in New Jersey; a program structure that is expensive and one that limits patients’ access to high grade medical cannabis. Considering that there are only five alternative treatment centers in New Jersey, from the onset, CSATC has made constant efforts to provide patients with greater accessibility to the most affordable and the highest quality medicine.

CSATC is involved in constant research and development. We recently purchased new extraction instrumentation to improve the quality of our extract products. The new upgrade enhances our extracting ability by eliminating the post decarboxylation process. Eliminating this process minimizes the degradation of concentrate, which results in an increased clarity in our oil. In addition, our extract process has recently been enhanced, and utilizes a two stage distillation process to fully remove waxes allowing for higher concentration recovery and less non-targeted compounds. These recent improvements in our extracting abilities are noticeable in the physical clarity of our topical oil as well as improved taste, smell and provide an increase in the clarity of effects among our extract products.

Largest and most consistent variety of medical cannabis strains. Our growers are constantly working to improve strains by methodically adjusting grow conditions to maximize the medicinal components for patients. We are currently growing six new strains that will be announced before the end of the year. CSATC’s patient base is constantly growing, and to match the demand, our facility has been approved to expand an additional 23,000 square feet giving room for an additional 500 lights. In the short term, this will allow CSATC to grow enough medicine to supply our growing patient base. Our long term plan is to turn our existing building into our cultivation and processing location, and open a larger, better suited CSATC dispensary across the street from our existing location.

These efforts will enhance CSATC’s ability to provide the highest quality medical cannabis strains and products at even more affordable prices. Our mission is to help relieve the pain and suffering of patients with serious diseases, and in order to accomplish this goal, CSATC has implemented different initiatives to make our medical cannabis more accessible and affordable for patients in the New Jersey Medical Marijuana Program.

Pricing
When CSATC opened, our prices were set below market value, but we knew that this wouldn’t be the end of our effort to improve patients’ access to medicine. Since then, we have expanded our hours of operation instituting the largest range of hours in the state for patients to purchase medicinal cannabis.

CSATC is unique in that our prices can be taken at face value. The prices patients see already includes the 6.875 percent state sales tax. CSATC is currently lobbying for the removal of the medical cannabis state sales tax, which would further reduce prices for patients. Over the past three months CSATC has reduced flower prices by more than 20 percent on over 12 top strains, and has increased the variety of featured strains in hopes that more patients will find the right strains for their debilitating medical condition. We also offer additional discounts including the Veteran’s Discount of 20%, the Compassionate Discount of 20% for those on government assistance and a Minor’s Discount of 40%.

As part of our hands-on approach to improve the New Jersey cannabis industry for patients, Executive Director George Schidlovsky has positioned himself on the board of directors for the New Jersey CannaBusiness Association, a powerful and active association whose mission is to guide the decision makers and regulators in the budding cannabis industry to understand and respect the needs of the CannaBusiness community.

 

Posted on in category: Cannabis News, New Jersey News, Dispensary News | Comments Off on CSATC’s Improvements, New Strains and More

Concerns Regarding The Supply of Hemp Based CBD from Sources Outside of The New Jersey Medical Marijuana Program

Recently, some of our patients have been exploring other sources of CBD and trying new Hemp-based products. It’s important to be aware that Hemp-based CBD is not always what it claims to be. Our major concern with the supply of Hemp based CBD from sources outside of the New Jersey Medical Marijuana Program (MMP) is that these sources do not adhere to the same rigorous growing and testing criteria of the New Jersey MMP, and may be exposing already suffering patients to harmful chemicals or pesticides. 

Sources of CBD from industrial hemp raises multiple concerns. Industrial hemp is not restricted in the use of pesticides and fertilizers as New Jersey medical cannabis is. Hemp, a known bioaccumulator, will absorb and collect these contaminants that can cause serious health problems if ingested. Also, companies producing these CBD products may purchase hemp from sources outside the U.S. further raising health concerns if these products are safe for patients to consume. The state of New Jersey tests all of the medical marijuana products produced in the state for consumption, and these outsourced CBD products are not tested within the state criteria.

 

Posted on in category: Cannabis News | Tagged , , , | Comments Off on Concerns Regarding The Supply of Hemp Based CBD from Sources Outside of The New Jersey Medical Marijuana Program

CSATC Educational Event Crohn’s and Colitis June 22

Beyond providing increasing accessibility to medicinal cannabis and being an active voice in the developing cannabis industry, CSATC will continue to provide education events for patients. We are finding that patients are enjoying our educational events, and that they provide an even greater sense of community surrounding our ATC. If you haven’t had the chance to attend our patient educational events, please stay tuned for upcoming events. We are hosting a Crohn’s and Colitis event on June 22. For more information or to RSVP, please call CSATC at (856) 933-8700.

Posted on in category: Dispensary News, Educational Events | Comments Off on CSATC Educational Event Crohn’s and Colitis June 22

Approval of New Qualifying Conditions Still Pending

In early May, the Medicinal Marijuana Review panel voted 5-1 to approve new qualifying conditions including different types of chronic pain, Tourette’s syndrome, Irritable Bowel Syndrome and anxiety related to Autism or Alzheimer’s disease. The board voted against recommending medical cannabis for treating asthma and chronic fatigue.  Although the board has voted to approve these conditions, after a 60 day period and another public hearing, the decision to add the conditions comes down to Health Commissioner Cathleen Bennett who was appointed by Gov. Chris Christie. The program’s already limited list restricts those who suffer from chronic pain to qualify if it’s a result of cancer or HIV/AIDS, even though many patients in the program experience chronic pain as a symptom of their qualifying condition.

The New Jersey Medical Marijuana Program has been criticized for being too restrictive, but its recent growth has been attributed to a series of small changes.

Ken Wolski, executive director of the Coalition of Medical Marijuana New Jersey, told the Philadelphia Inquirer that the approval of chronic pain could potentially allow 150,000 chronic pain suffers to join the New Jersey’s Medical Marijuana Program. According to the health department there are currently 11,659 patients enrolled in New Jersey’s Medical Marijuana Program. Upon the addition of chronic pain, regulatory adjustments may be necessary for ATCs to successfully supply the oncoming surge of patients.

 

Posted on in category: Qualifying Conditions, New Jersey News | Tagged | Comments Off on Approval of New Qualifying Conditions Still Pending

Qualifying Condition Focus: Crohn’s Disease and Colitis

This month we are highlighting Crohn’s disease and Colitis, which are classified as Inflammatory Bowel Diseases and listed as a qualifying condition for the New Jersey Medical Marijuana Program.

There is no “cures” for Crohn’s disease or Colitis, and most treatments are aimed to ease inflammation, prevent flare-ups and keep patients in remission. Considering that patients may have to take medicine constantly to keep these conditions under control, medical cannabis may be a viable, less harmful alternative medicine for their symptoms.

Crohn’s Disease and Colitis are Inflammatory Bowel Diseases that are defined by parts of the digestive system becoming swollen and having deep sores known as ulcers. Crohn’s Disease is usually apparent in the end of the small intestine and the beginning of the large intestine, but it has been found in other places along the digestive tract. Colitis, on the other hand, often only affects the colon and the rectum.
The direct cause of Crohn’s Disease and Colitis is unknown. It is thought that people may develop Crohn’s Disease or Colitis when their body has an abnormal response to the bacteria in their intestines, or other bacteria and viruses may play a role in causing the disease. The diseases may also be hereditary.

CSATC carries multiple strains that patients say have positive effects in treating gastrointestinal issues. For example, ACDC, Blue Dream and Willy Jack tend to be patient favorites for helping these issues.

Typically strains with higher CBG help regulate the digestive tract.

The symptoms of Crohn’s Disease and Colitis are stomach pain, diarrhea and weight loss. Some patients may experience diarrhea 10 to 20 times a day, sometimes with blood in their stool. Other less common symptoms of Crohn’s disease include mouth sores, bowel blockages, fissures (anal tears) and openings (fistulas) between organs.

Some of the more recent research on medical cannabis use for Inflammatory Bowel Diseases is promising. A study published in 2011 in the Israel Medical Association Journal focused on 30 patients who had not responded to standard treatments.  Twenty-one of the patients said their overall well-being improved with cannabis use, and the need for other medication was significantly reduced.

Studies have suggested that THC administration was associated with delayed gastric emptying of a standard solid and liquid meal. A second study by the same group demonstrated that THC was associated with relaxation of the colon and inhibition of the increase in tone after a meal.

Posted on in category: Qualifying Conditions | Comments Off on Qualifying Condition Focus: Crohn’s Disease and Colitis

Easy ‘Peasy’ Brownies

Easy ‘Peasy’ Brownies

1 Box Brownie Mix
2/3 C. Cannabis Coconut Oil, infused with CS Cocoa Butter
¼ C. Water
2 Eggs
Chocolate Chips, as much or little preferred

Instructions:

Mix all ingredients.
Put in greased baking pan at 325 degrees for about 35 minutes, or until toothpick inserted in brownies comes out clean.

 

Posted on in category: Patient Recipes | Comments Off on Easy ‘Peasy’ Brownies
Top